X2M Connect has successfully completed an oversubscribed capital raise, securing $5.4 million to strengthen its balance sheet and accelerate growth across Asia and the Middle East.
LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.